$0,98
▲ +$0,03
(+3,16%)
Vol. 61K
5
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$19.6M
ROE
-103,4%
Margine
-10,0%
D/E
79,15
Beta
0,73
52W
$1–$2
Consenso Wall Street
7 analisti · Apr 20262
Acquisto forte
4
Compra
1
Mantieni
0
Vendi
0
Vendita forte
85,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 80,0%
Prossimo report
Mag 11, 2026
Stima EPS: $-0,07
| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Mar 2026 | $-0,07 | — | — |
| Dic 2025 | $-0,02 | $-0,01 | +$0,01 |
| Set 2025 | $-0,06 | $-0,09 | $-0,03 |
| Giu 2025 | $-0,09 | $-0,06 | +$0,03 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Ricavi | $11.6M | $12.7M | $11.9M | $13.6M | $12.5M |
| Utile netto | -$1.9M | -$834K | -$1.7M | -$994K | -$1.6M |
Trend fondamentali
| Metrica | 2025-06-28 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -123.6% | -180.4% | -123.6% | -123.6% | -123.6% | -103.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -7.3% | -14.6% | -10.9% | -10.9% | -10.9% | -10.0% |
| Gross Margin | 34.5% | 41.2% | 39.5% | 39.5% | 39.5% | 38.2% |
| D/E Ratio | 60.65 | 53.18 | 60.65 | 60.65 | 60.65 | 79.15 |
| Current Ratio | 1.96 | 1.95 | 1.96 | 1.96 | 1.96 | 1.94 |
Rapporti chiave
ROA (TTM)
-16,5%
P/S (TTM)
0,39
P/B
13,8
EPS (TTM)
$-0,30
CF/Share
$-0,34
Crescita ricavi 3A
-3,4%
52W High
$1,89
52W Low
$0,78
$0,78
Intervallo 52 settimane
$1,89
Salute finanziaria
Flusso di cassa libero
-$1.2M
Debito netto
-$788K
Liquidità
$5.6M
Debito totale
$4.8M
Aggiornato al Set 30, 2025
Як IRIX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка IRIX vs аналоги Health Care
P/E
—
▼
0%
sotto
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
0,4
▼
85%
sotto
peer
(2,6)
vs Peer
vs Settore
Sottovalutato
P/B
13,8
▲
397%
sopra
peer
(2,8)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість IRIX vs аналоги Health Care
ROE
-103,4%
▼
168%
sotto
peer
(-38,5%)
vs Peer
vs Settore
Debole
Net margin
-10,0%
▲
59%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Sotto media
Валова маржа
38,2%
▼
28%
sotto
peer
(52,9%)
vs Peer
vs Settore
Debole
ROA
-16,5%
▲
22%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Sotto media
Фінансове здоровʼя IRIX vs аналоги Health Care
D/E ratio
79,2
▲
311%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,9
▼
10%
sotto
peer
(2,2)
vs Peer
vs Settore
In linea
Beta
0,7
▼
31%
sotto
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів IRIX
IRIX
Mediana peer
Industria
IRIX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
IRIX vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
DIZON ROMEO R
Chief Financial Officer · Mar 06
1110 shs
DIZON ROMEO R
Chief Financial Officer · Feb 17
2200 shs
DIZON ROMEO R
Chief Financial Officer · Feb 12
1500 shs
DIZON ROMEO R
Chief Financial Officer · Feb 10
1000 shs
DIZON ROMEO R
Chief Financial Officer · Feb 03
2500 shs
DIZON ROMEO R
Chief Financial Officer · Gen 29
1101 shs
DIZON ROMEO R
Chief Financial Officer · Gen 28
1300 shs
DIZON ROMEO R
Chief Financial Officer · Gen 27
3385 shs
DIZON ROMEO R
Chief Financial Officer · Gen 26
1243 shs
DIZON ROMEO R
Chief Financial Officer · Gen 23
5221 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 13,65%Paragon Associates & Parago…
5,82%
$1.0M
Vanguard Group Inc
3,37%
$584K
Renaissance Technologies, L…
2,16%
$375K
Weber Capital Management LL…
1,51%
$262K
Geode Capital Management, L…
0,79%
$137K
Aggiornato al Dic 31, 2025